HC Wainwright & Co. Reiterates Buy on Biophytis, Maintains $15 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Joseph Pantginis has reiterated a 'Buy' rating on Biophytis (NASDAQ:BPTS) and maintained a $15 price target.
August 08, 2023 | 4:31 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated a 'Buy' rating on Biophytis and maintained a $15 price target, which could positively impact the stock's performance.
Analyst ratings and price targets can significantly influence investor sentiment and stock performance. The reiteration of a 'Buy' rating and a maintained price target of $15 by HC Wainwright & Co. indicates a positive outlook for Biophytis, which could lead to an increase in its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100